BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11757182)

  • 21. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients.
    Haque W; Voong KR; Shihadeh F; Arzu I; Pinnix C; Mazloom A; Medeiros LJ; Romaguera J; Rodriguez A; Wang M; Allen P; Dabaja B
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):474-9. PubMed ID: 25108680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages.
    Andrieu JM; Jais JP; Colonna P; Desablens B; Brière J; François S; Harousseau JL; Casassus P; Lemevel A; Le Prisé PY; Ghandour C; Guilhot F; Lejeune F
    Ann Oncol; 1998 Feb; 9(2):195-203. PubMed ID: 9553666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: a preliminary report.
    Chien CR; Chen SW; Hsieh CY; Liang JA; Yang SN; Huang CY; Lin FJ
    Jpn J Clin Oncol; 2001 Feb; 31(2):55-60. PubMed ID: 11302342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
    Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
    Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.
    Bradley JD; Wahab S; Lockett MA; Perez CA; Purdy JA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):342-7. PubMed ID: 12738307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival.
    Poen JC; Hoppe RT; Horning SJ
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):3-12. PubMed ID: 8823253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
    Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
    J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiotherapy alone in early stages of low malignancy non-Hodgkin lymphomas].
    Engelhard M; Sack H
    Praxis (Bern 1994); 1998 Jun; 87(23):801-5. PubMed ID: 9654986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results with radiotherapy for Stage I-II follicular lymphomas.
    Wilder RB; Jones D; Tucker SL; Fuller LM; Ha CS; McLaughlin P; Hess MA; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1219-27. PubMed ID: 11728680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.
    Tubiana M; Henry-Amar M; Hayat M; Burgers M; Qasim M; Somers R; Sizoo W; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):197-210. PubMed ID: 6368491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
    Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
    J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
    Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
    Mundt AJ; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):261-70. PubMed ID: 7673013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience.
    Chua DT; Sham JS; Choy D; Kwong DL; Au GK; Kwong PW; Yau CC; Cheng AC; Wan KY
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1219-28. PubMed ID: 11286826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Follicle centre lymphoma: treatment results for stage I and II].
    Neumann H; Blanck H; Koch R; Fiedler S; Lesche A; Herrmann T
    Strahlenther Onkol; 2003 Dec; 179(12):840-6. PubMed ID: 14652673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
    Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
    N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.